These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16327856)

  • 1. [Molecular genetics in the diagnosis of bone and soft tissue tumours].
    Bjerkehagen B; Myklebost O
    Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3286-9. PubMed ID: 16327856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of genetic testing in soft tissue sarcoma.
    Antonescu CR
    Histopathology; 2006 Jan; 48(1):13-21. PubMed ID: 16359533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib.
    Loughrey MB; Trivett M; Beshay V; Dobrovic A; Kovalenko S; Murray W; Lade S; Turner H; McArthur GA; Zalcberg J; Waring PM
    Histopathology; 2006 Jul; 49(1):52-65. PubMed ID: 16842246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome banding analysis of cells from fine-needle aspiration biopsy samples from soft tissue and bone tumors: is it clinically meaningful?
    Walther C; Domanski HA; von Steyern FV; Mandahl N; Mertens F
    Cancer Genet; 2011 Apr; 204(4):203-6. PubMed ID: 21536238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soft tissue tumours: the impact of cytogenetics and molecular genetics.
    Fletcher CD
    Verh Dtsch Ges Pathol; 1997; 81():318-26. PubMed ID: 9474886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Kit/PDGFRA gene status alterations possibly related to primary imatinib resistance in gastrointestinal stromal tumors.
    Miselli FC; Casieri P; Negri T; Orsenigo M; Lagonigro MS; Gronchi A; Fiore M; Casali PG; Bertulli R; Carbone A; Pierotti MA; Tamborini E; Pilotti S
    Clin Cancer Res; 2007 Apr; 13(8):2369-77. PubMed ID: 17438095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitotic instability associated with late genomic changes in bone and soft tissue tumours.
    Gisselsson D; Pålsson E; Yu C; Mertens F; Mandahl N
    Cancer Lett; 2004 Mar; 206(1):69-76. PubMed ID: 15019162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors.
    Janeway KA; Liegl B; Harlow A; Le C; Perez-Atayde A; Kozakewich H; Corless CL; Heinrich MC; Fletcher JA
    Cancer Res; 2007 Oct; 67(19):9084-8. PubMed ID: 17909012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcoma molecular testing: diagnosis and prognosis.
    Lazar AJ; Trent JC; Lev D
    Curr Oncol Rep; 2007 Jul; 9(4):309-15. PubMed ID: 17588356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Soft tissue sarcomas: update on molecular data].
    Bui Nguyen Binh M; Collin F; Coindre JM
    Cancer Radiother; 2006; 10(1-2):15-21. PubMed ID: 16442827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-treatment complications of soft tissue tumours.
    Shapeero LG; De Visschere PJ; Verstraete KL; Poffyn B; Forsyth R; Sys G; Uyttendaele D
    Eur J Radiol; 2009 Feb; 69(2):209-21. PubMed ID: 19101106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative validation of c-kit exon 11 mutation analysis on cytology samples and corresponding surgical resections of gastrointestinal stromal tumours.
    Pang NK; Chin SY; Nga ME; Chang AR; Ismail TM; Omar SS; Charlton A; Salto-Tellez M
    Cytopathology; 2009 Oct; 20(5):297-303. PubMed ID: 19207305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical and molecular study of gastrointestinal stromal tumours.
    Teong YT; Teo ST; Tan LP; Wu BQ; Peh SC
    Med J Malaysia; 2006 Dec; 61(5):526-33. PubMed ID: 17623951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant fibrous histiocytoma of bone: analysis of genomic imbalances by comparative genomic hybridisation and C-MYC expression by immunohistochemistry.
    Tarkkanen M; Larramendy ML; Böhling T; Serra M; Hattinger CM; Kivioja A; Elomaa I; Picci P; Knuutila S
    Eur J Cancer; 2006 May; 42(8):1172-80. PubMed ID: 16630715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promiscuous genes involved in recurrent chromosomal translocations in soft tissue tumours.
    Antonescu CR; Dal Cin P
    Pathology; 2014 Feb; 46(2):105-12. PubMed ID: 24378390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors.
    Dobashi Y; Suzuki S; Sugawara H; Ooi A
    Hum Pathol; 2007 Jun; 38(6):914-25. PubMed ID: 17376509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of cytogenetics to the management of poorly differentiated sarcomas.
    Bridge JA
    Ultrastruct Pathol; 2008; 32(2):63-71. PubMed ID: 18446669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A histopathological review of gastrointestinal related mesenchymal tumors: the hidden GIST.
    Issakov J; Jiveliouk I; Nachmany I; Klausner J; Merimsky O
    Isr Med Assoc J; 2007 Nov; 9(11):810-2. PubMed ID: 18085040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetics and molecular genetics of bone and soft-tissue tumors.
    Sandberg AA
    Am J Med Genet; 2002 Oct; 115(3):189-93. PubMed ID: 12407700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.